Brewing giant Heineken warns British pubs that the boom in weight-loss jabs such as Wegovy could hit beer sales

Heineken, the world's second-largest brewer, has flagged that weight-loss drugs such as Wegovy may diminish people's appetite for alcohol. An internal company document outlines its worries about the implications of the weight-loss drug craze for beer sales.

The warning is directed specifically at Britain's pubs.